The gamma-secretase complex is an intramembrane aspartyl protease comprised of at least four known subunits: Presenilin (PS), Nicastrin (Nct), Aph, and Pen2. Presenilin is the catalytic subunit of the complex. Mutations in PS1 and PS2, which lead to familial early-onset Alzheimer disease, alter the activity and specificity of gamma-secretase. Investigation of gamma-secretase specificity and development of gamma-secretase based therapies have been a huge challenge because of its nature of intramembranal catalysis and macromolecular complex as well as cleavage of multiple substrates. We have developed an integrated approach of biochemistry, chemical biology and cell biology for the study of gamma-secretase structure and function. We will discuss how to apply this approach to elucidate the role endogenous and exogenous factors in regulation of gamma-secretase. We will focus on the development of chemical probes and utilize them to define the mechanism of action of gamma-secretase modulators.
. 2013 Sep 13;8(Suppl 1):O10. doi: 10.1186/1750-1326-8-S1-O10
Endogenous and exogenous regulation of gamma-secretase
Yueming Li
1,✉
Yueming Li
1Molecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer Center, New York, USA
Find articles by Yueming Li
1Molecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer Center, New York, USA
✉
Corresponding author.
Supplement
Molecular Neurodegeneration: Basic biology and disease pathways
Publication costs for this supplement were funded by the publisher.
Conference
10-12 September 2013
Molecular Neurodegeneration: Basic biology and disease pathways
Cannes, France
Collection date 2013.
Copyright © 2013 Li; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
PMCID: PMC3847065
